Enhance MD vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Enhance MD beats MEDVi overall, scoring 7.8/10 vs 7.7/10. Enhance MD is more affordable at $212/mo vs $299/mo. Choose Enhance MD for budget-conscious users interested in combination therapies. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side comparison of Enhance MD and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Enhance MD

#18 of 48

7.8/10

Affordable telehealth provider offering both compounded and brand-name GLP-1 medications with combination therapy options.

Visit Enhance MD

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Enhance MD	MEDVi
Our Score	7.8/10	7.7/10
Starting Price	$212/mo	$299/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious users interested in combination therapies	Users who want a low entry price with oral and injectable compounded options
Ranking	#18	#22

Pros & Cons Compared

Enhance MD

Pros

+$115/mo starting price with access to both brand-name and compounded — rare at this price point
+Offers combination therapies (GLP-1 + B12, GLP-1 + NAD+) for patients wanting enhanced protocols
+Quick asynchronous consultations — most patients approved within 24 hours without video calls
+Flexible dosing: can start at lower doses than standard protocols for sensitive patients

Cons

−Lighter clinical support than higher-priced platforms — check-ins are patient-initiated, not scheduled
−No insurance billing and limited customer support hours (business days only, no weekends)

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

Enhance MD edges out MEDVi with a score of 7.8/10 vs 7.7/10. If budget is your priority, Enhance MD starts at $212/mo compared to MEDVi's $299/mo. Choose Enhance MD if you want: budget-conscious users interested in combination therapies. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Enhance MD nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review